Compare HAS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAS | BME |
|---|---|---|
| Founded | 1923 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 536.7M |
| IPO Year | N/A | N/A |
| Metric | HAS | BME |
|---|---|---|
| Price | $82.25 | $41.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $88.55 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 34.0K |
| Earning Date | 10-23-2025 | 01-01-0001 |
| Dividend Yield | 3.42% | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $4,357,000,000.00 | N/A |
| Revenue This Year | $10.26 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 0.79 | N/A |
| 52 Week Low | $49.00 | $35.53 |
| 52 Week High | $85.15 | $43.20 |
| Indicator | HAS | BME |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 61.19 |
| Support Level | $79.48 | $40.41 |
| Resistance Level | $82.51 | $41.12 |
| Average True Range (ATR) | 1.97 | 0.40 |
| MACD | -0.17 | -0.06 |
| Stochastic Oscillator | 43.02 | 94.87 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.